Are Endocan Plasma Levels Altered in Preeclampsia?
Sábháilte in:
Príomhchruthaitheoirí: | Ana Cristina dos Santos Lopes (Údar), Suellen Rodrigues Martins (Údar), Luci Maria SantAna Dusse (Údar), Melina de Barros Pinheiro (Údar), Patrícia Nessralla Alpoim (Údar) |
---|---|
Formáid: | LEABHAR |
Foilsithe / Cruthaithe: |
Federação Brasileira das Sociedades de Ginecologia e Obstetrícia,
2021-05-01T00:00:00Z.
|
Ábhair: | |
Rochtain ar líne: | Connect to this object online. |
Clibeanna: |
Cuir clib leis
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|
Míreanna comhchosúla
Míreanna comhchosúla
-
Longitudinal assessment of D-dimer and plasminogen activator inhibitor type-1 plasma levels in pregnant women with risk factors for preeclampsia
de réir: Flávia Campos Lucena, et al.
Foilsithe / Cruthaithe: (2019) -
Complete blood count as a biomarker for preeclampsia with severe features diagnosis: a machine learning approach
de réir: Daniella Castro Araújo, et al.
Foilsithe / Cruthaithe: (2024) -
Avaliação do dímero D (D-Di) na doença hipertensiva específica da gravidez (DHEG) D-dimer plasma levels assessment in preeclampsia
de réir: Luci Maria Sant'Ana Dusse, et al.
Foilsithe / Cruthaithe: (2003) -
Plasma endocan level and prognosis of immunoglobulin A nephropathy
de réir: Yu Ho Lee, et al.
Foilsithe / Cruthaithe: (2016) -
Early and late-onset preeclampsia: effects of DDAH2 polymorphisms on ADMA levels and association with DDAH2 haplotypes
de réir: Fernanda Santos Mendes, et al.
Foilsithe / Cruthaithe: (2024)